Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis

Company Overview

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery. In the Ophthalmic Devices segment, Carl Zeiss Meditec develops and markets diagnostic instruments such as optical coherence tomography (OCT) systems, fundus cameras and tonometers, as well as therapeutic laser platforms for refractive surgery and cataract treatment. Within Microsurgery, the firm produces high-precision surgical microscopes and handheld visualization tools that serve specialties including neurosurgery, ear-nose-throat (ENT) and dentistry. Each product line is designed to deliver enhanced image quality, ergonomic operation and reliable performance in clinical environments.

Operating across Europe, the Americas, Asia-Pacific and select emerging markets, Carl Zeiss Meditec maintains a broad international sales and service network. The company collaborates closely with hospitals, clinics and research institutions to support clinical training and product development. Its global footprint is supported by regional offices, production sites and service centers, ensuring timely access to technical support and spare parts.

Governed by a management board of experienced executives in optics, medical technology and healthcare, Carl Zeiss Meditec continues to emphasize research and development. The company reinvests a significant portion of its revenues into new technologies, with the aim of advancing patient outcomes and increasing surgical precision. Through ongoing innovation and strong aftermarket support, Carl Zeiss Meditec remains a key partner for healthcare professionals worldwide.

Key Stats

• Today's Range: $32.25 to $32.72
• 50-Day Range: $28.41 to $35.67
• 52-Week Range: $26.65 to $59.10
• Volume: 503 shs
• Average Volume: 4,644 shs
• Market Capitalization: N/A
• P/E Ratio: 35.23
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Carl Zeiss Meditec Stock Analysis - MarketRank™

Carl Zeiss Meditec scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Hold

Consensus Rating

Carl Zeiss Meditec has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 1 buy rating, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Carl Zeiss Meditec has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Carl Zeiss Meditec is 35.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.96.

Price to Earnings Ratio vs. Sector

The P/E ratio of Carl Zeiss Meditec is 35.23, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.20.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Carl Zeiss Meditec has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Carl Zeiss Meditec has recently decreased by 96.42%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Carl Zeiss Meditec does not currently pay a dividend.

Dividend Growth

Carl Zeiss Meditec does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: N/A

News Sentiment

Carl Zeiss Meditec has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Carl Zeiss Meditec this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.10% of the stock of Carl Zeiss Meditec is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CZMWY
• CIK: N/A
• Web: www.zeiss.com
• Phone: 493641220115
• Fax: N/A
• Employees: 4,823
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 35.23
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A